R. John Fletcher is a businessperson who founded Fletcher Spaght, Inc. and Fletcher Spaght Venture Partners LLC and who has been at the helm of 6 different companies. Currently, he holds the position of Chairman for Repro-Med Systems, Inc., Chairman for Metabolon, Inc., Chairman at Clearpoint Neuro, Inc., Chairman of Vyant Bio, Inc., Chief Executive Officer & Managing Partner at Fletcher Spaght, Inc., Founding Partner of Fletcher Spaght Venture Partners LLC (a subsidiary of Fletcher Spaght, Inc.) and Principal at Catalyst Acquisition Group LLC.
He is also on the board of OptiNose, Inc. and Sumitomo Eaton Nova Corp. and Chairman-Corporate Collaboration Council at Thayer School of Engineering At Dartmouth.
In the past R. John Fletcher occupied the position of Manager of The Boston Consulting Group, Inc., Director at 4DataLink, Inc. and Director at Spectranetics LLC.
Dr. Fletcher received an MBA from Southern Illinois University, an undergraduate degree from George Washington University, a graduate degree from Central Michigan University and a graduate degree from The Wharton School of the University of Pennsylvania.